Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry.

Clinica chimica acta; international journal of clinical chemistry - 15 Jul 2011

Boemer François, Cornet Yves, Libioulle Cécile, Segers Karin, Bours Vincent, Schoos Roland

Abstract excerpt

BACKGROUND: Neonatal screening programs for sickle cell disease are common in North America and in some European countries. Isoelectric Focusing or High Performance Liquid Chromatography is the main technique used for hemoglobin variant detection. METHODS: Since tandem mass spectrometry is being used for screening of inherited metabolic disorders and allows protein identification, we had developed an application...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal Hemoglobin
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Infant, Newborn

Share to Metabolism, Inborn Errors

Share to Mutation

Share to Neonatal Screening

Share to Sensitivity and Specificity

Share to Tandem Mass Spectrometry

Source

Identifiers

PMID: 21569767
DOI: 10.1016/j.cca.2011.04.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry.PMID 21569767Read ↗

Phenotype determination of hemoglobinopathies by mass spectrometry.Semantic proximity Read ↗

Newborn Screening for Fabry Disease: Current Status of KnowledgeSemantic proximity Read ↗

Strategy linking several analytical methods of neonatal screening for sickle cell disease.Semantic proximity Read ↗

Identification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass SpectrometrySemantic proximity Read ↗

Potential of the Sebia Capillarys neonat fast automated system for neonatal screening of sickle cell disease.Semantic proximity Read ↗

Neonatal screening for haemoglobinopathies: the results of a 10‐year programme in an English Health RegionSemantic proximity Read ↗

A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fractionSemantic proximity Read ↗

Neonatal Screening for Sickle Cell Disease in CongoSemantic proximity Read ↗

Mass spectrometry: a tool for enhanced detection of hemoglobin variants.Semantic proximity Read ↗

Newborn screening for hemoglobinopathies using capillary electrophoresis.Semantic proximity Read ↗

Four years of expanded newborn screening in Portugal with tandem mass spectrometry.Semantic proximity Read ↗

Rapid identification of hemoglobin variants by electrospray ionization mass spectrometry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.